Prior studies have demonstrated that combined treatment of testosterone with a progestin induces a more rapid and greater suppression of spermatogenesis than testosterone treatment alone. We hypothesized that the suppressive effects of the combination of testosterone undecanoate (TU) injections plus oral levonorgestrel (LNG) on spermatogenesis may be mediated through a greater perturbation of testicular gene expression than TU alone. To test this hypothesis, we performed open testicular biopsy on 12 different adult healthy subjects: 1) four healthy men as controls; 2) four men 2 wk after TU treatment; and 3) four men 2 wk after TU + LNG administration. RNA isolated from biopsies was used for DNA microarray using the Affymetrix Human Genome U133 Plus 2.0 oligonucleotide microarrays. Gene expression with !2-fold changes (P , 0.05) compared with control was analyzed using the National Institutes of Health Database for Annotation, Visualization, and Integrated Discovery 2008 resource. The TU treatment altered the gene expression in 109 transcripts, whereas TU + LNG altered the gene expression in 207 transcripts compared with control. Both TU and TU + LNG administration suppressed gene expression of insulin-like 3; cytochrome P450, family 17, subfamily A1 in Leydig cells; and inhibin alpha in Sertoli cells; they increased proapoptotic transcripts BCL2-like 14, insulin-like growth factor-binding protein 3; and they decreased X-linked inhibitor of apoptosis protein. In comparison with TU treatment alone, TU + LNG treatment upregulated insulin-like 6 and relaxin 1, and downregulated RNA-binding protein transcripts. We conclude that TU + LNG administration induces more changes in testicular gene expression than TU alone. This exploratory study provided a novel and valuable database to study the mechanisms of action of hormonal regulation of spermatogenesis in men and identified testicular-specific molecules that may serve as potential targets for male contraceptive development.
INTRODUCTION
Hormonal male contraception is achieved through the suppression of both luteinizing hormone (LH) and folliclestimulating hormone (FSH), and a decrease in intratesticular testosterone which, in turn, leads to the reliable and reversible suppression of spermatogenesis to azoospermia or severe oligozoospermia. Clinical studies have evaluated the contraceptive efficacy of spermatogenic suppression with combined administration of an androgen and a progestin at doses that maintain physiological serum testosterone levels [1] . The combination of a progestin and testosterone promotes more rapid and greater spermatogenic suppression than that of testosterone alone. The enhanced efficacy of the combined regimen allows a lower dose of testosterone to be used, thus reducing potential androgen-related side effects [2, 3] . Although progestins are generally thought to enhance the efficacy of androgens in the suppression of gonadotropin secretion, other mechanisms of the action of the combined hormonal treatment regimen on testes are possible.
In prior studies in rats, monkeys and humans, we have demonstrated that exogenous testosterone administration leads to accelerated germ cell apoptosis; we believe this proapoptotic effect is one of the principal mechanisms in testosteroneinduced suppression of spermatogenesis [4] [5] [6] . In a prior manuscript, we showed that the addition of levonorgestrel (LNG) to a physiological dose of testosterone undecanoate (TU) treatment to men increased germ cell apoptosis more than TU treatment alone and resulted in a more rapid and greater suppression of spermatogenesis [4] . Other studies have provided additional evidence that treatment with combined testosterone and progestin also suppresses spermatogenesis by decreasing type B spermatogonia and impairing spermiation, leading to spermatozoa retention in rodents, monkey, and men [7, 8] . Although in our prior report [4] we did not find a significant change in germ cell apoptosis 2 wk after either TU or TU þ LNG treatment in human testes, a recent study by other investigators reported increased spermatogonia apoptosis 2 wk after gonadotropin suppression induced by testosterone enanthate (TE) or TE combined with depot medroxyprogesterone acetate injections [9] . Two weeks of gonadotropin suppression also cause measurable changes to spermatogonial numbers in monkeys and men [7, 10] . To further understand the molecular mechanisms of the apparently greater effects of LNG on suppression of spermatogenesis induced by testosterone in the testis and to identify potential molecular targets for future male contraceptive development, we performed gene microarray analyses on testicular samples obtained from healthy male volunteers and men treated for 2 wk with either TU injections alone or TU plus LNG (TU þ LNG). Biopsies obtained 2 wk after putative contraceptive administrations were selected for array analysis because our prior studies indicated no or minimal loss of germ cells at this time.
MATERIALS AND METHODS

Subjects and Study Design
This testicular gene expression study was a subproject of a previously reported clinical trial to study changes in semen parameters, testicular morphology, and germ cell apoptosis in healthy male volunteers after TU or TU þ LNG treatment [4] . In brief, in the main study healthy volunteer men (age range, 35-48 yr; mean 6 SEM, 40.5 6 4.2 yr) with proven fertility were recruited by the Jiangsu Family Planning Research Institute (Nanjing, China). All subjects had a normal physical examination, semen analysis, normal baseline hematology, blood biochemistry, urinalysis, and fasting lipid profile before entering the study [4] . They were randomized to different treatment groups (n ¼ 18 per group), including the TU group (1000-mg intramuscular injection of TU followed by 500 mg TU intramuscularly every 6 wk for 18 wk) and TU þ LNG group (TU treatment together with LNG [250 lg] orally daily for 18 wk). The subjects then were observed for another 12 wk until the return of sperm concentration to within the reference intervals of adult men. Twelve subjects were recruited to participate in the testicular biopsy substudy; refusal to participate in the testicular biopsy study did not exclude them from the main study [4] . We obtained testicular biopsies from four men in each group: 1) before treatment serving as control, 2) 2 wk after TU treatment; and 3) 2 wk after TU þ LNG administration. None of the participants had more than one testicular biopsy. The ethics committees at the First Affiliated Hospital of Nanjing Medical University, Jiangsu Family Planning Research Institute, and the Institutional Review Board of the Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute approved our study protocols. All subjects signed written informed consent.
Testicular Biopsy Procedure and Tissue Preparation
Each subject received one open testicular biopsy. Open unilateral testicular biopsy was performed under local anesthesia by experienced surgeons at the First Affiliated Hospital of Nanjing Medical University, China. Each biopsy was divided into three portions. One portion was fixed in Bouin solution for morphological analysis and immunohistochemistry [4] , another was frozen in liquid nitrogen for protein analysis [11] , and the third was stored in RNAlater (Ambion Inc., Austin, TX) for gene expression studies (see below). None of the subjects had adverse effects from the testicular biopsies except temporary mild testicular pain that required no treatment. Proteins isolated from testicular biopsies were subjected to two-dimensional gel electrophoresis and matrixassisted laser desorption/ionization-time-of-flight mass spectrometry to assess the protein changes; these data have been published elsewhere [11] .
DNA Microarray
RNA extraction and DNA microarray were performed at the UCLA DNA Microarray Core. In brief, total RNA was isolated from human testicular biopsies and purified by RNeasy Mini Kit spin columns (Qiagen, Valencia, CA). RNA quality was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Wilmington, DE). Total RNA purified from each sample was used to synthesize biotinylated cRNA for the Affymetrix GeneChip Array (Human Genome U133 Plus 2.0 oligonucleotide microarray). Briefly, 5 lg total RNA was used to start cDNA synthesis using polydT-24 primer containing a T7 RNA promoter. Synthesis of biotin-labeled cRNA was performed using an Affymetrix RNA transcription labeling kit. The labeled cRNA was purified with RNeasy Mini kit spin columns (Qiagen). The cRNA then was hybridized for 16 h with the Human Genome U133 Plus 2.0 array, which interrogates 38 500 well-characterized human genes (Affymetrix GeneChip Technology, Santa Clara, CA). After hybridization, the chips were washed and stained with R-phycoerythrin-streptavidin, and the signal was amplified with antistreptavidin and scanned with a GeneChip Scanner 3000 (Affymetix). The intensity of each feature of the array was captured with an Affymetrix GeneChip Operating System, according to standard Affymetrix procedures. The mRNA abundance was determined based on the average of the differences between perfect match and intentional mismatch intensities for each probe set using Affymetrix Microarray Suite 5.0 (MAS 5.0 Affymetrix) algorithm. Data that met the MicroArray Quality Control threshold at the UCLA DNA Microarray Core were used for data analysis. One control sample did not pass the quality control threshold and was excluded from data analysis.
Microarray Data Analysis
The GeneChip Operating System-generated cel files of three controls, four TU-treated individuals, and four TU þ LNG-treated individuals were analyzed using GeneSpring GX software (Agilent Technologies). Probe-level summarization was performed using the GeneSpring built-in GCRMA algorithm.
The data set was normalized with GeneSpring default/recommended normalization methods, including data transformation set measurements less than 0.01 to 0.01; per chip normalized to 50th percentile; and per gene normalized to median. Principal component analysis was used to visualize global gene expression distribution of each sample. Principal component analysis is a vector space transformation method used to reduce multidimensional data sets to lower dimensions for visualization and analysis. As shown in Figure 1 , the three principal components accounted for 22.41%, 14.29%, and 11.4% of total variance, respectively. Although gene expression variability inevitably existed in the different subjects being studied, our principal component analysis showed that TU-and TU þ LNG-treated samples were clustered together and were distinguishably different from the control samples, indicating that the effects due to the treatments (TU or TU þ LNG) were significantly larger than the intragroup biological variation. To identify the differentially expressed genes regulated by either TU or TU þ LNG treatment, the probe sets with raw intensities less than 50 in all 11 GeneChips were first filtered out, then one-way ANOVA was conducted on the remaining probe sets to detect the probe sets that were statistically significant (P , 0.05) among groups [12] . Differentially expressed probe sets (transcripts) were defined as those probe sets that showed at least 2-fold change in either direction with a statistically significant difference (t-test, P , 0.05) compared with the control group. To further investigate the difference in gene expression between TU alone and TU þ LNG treatment, we conducted a Student t-test to determine the statistical difference between 109 transcripts induced by TU alone and 207 transcripts induced by TU þ LNG. 
Gene Functional Annotation and Clustering Analysis
Immunohistochemical Analysis
Bouin-fixed, paraffin-embedded testicular sections were deparaffinized, hydrated by successive series of ethanol, and rinsed in distilled water. Sections were incubated in 2% H 2 O 2 to quench endogenous peroxidases. Sections were blocked with 5% normal horse serum for 20 min to suppress nonspecific binding of immunoglobulin G (IgG) and were subsequently incubated with a monoclonal insulin-like growth factor-binding protein 3 (IGFBP3) antibody (R & D Systems, Minneapolis, MN) at room temperature for 1 h. The negative controls were processed in an identical manner, except the primary antibody was substituted with an anti-trpE mouse monoclonal antibody. Immunoreactivity was detected using biotinylated anti-mouse IgG secondary antibody followed by avidin-biotinylated horseradish peroxidase complex visualized with diaminobenzidine tetrahydrochloride per the manufacturer's instructions (mouse UniTectTM ABC Kit; Calbiochem, La Jolla, CA). Slides were counterstained with hematoxylin and viewed with the Zeiss Axioskop 40 microscope [13] .
RESULTS
Quantitative Changes in Gene Expression
Administration of TU alone or TU þ LNG suppressed gonadotropin secretion as previously reported [4] . The present study showed that after 2 wk of treatment, before any apparent loss of germ cells had occurred, TU þ LNG treatment resulted in greater alteration of testicular gene expression than TU treatment alone (Figs. 2 and 3) . Compared with controls, the statistically significant differentially expressed (P , 0.05) genes with !2-fold changes in TU alone and TU þ LNG treatment groups are shown in Figure 2 and provided in Supplemental Data (available at www.biolreprod.org). The TU treatment alone induced a total of 109 genes with significant changes (!2 fold; P , 0.05), in which 70 genes were upregulated and 39 genes were downregulated. In contrast, TU þ LNG treatment induced significant changes (!2 fold; P , 0.05) in 207 genes, including 92 upregulated and 115 downregulated genes. As shown in the Venn diagram (Fig.  3) , when compared with the control group, TU treatment significantly altered the expression of 51 genes, whereas TU þ LNG treatment significantly changed 149 genes. There were 58 genes showing the same changes caused by TU and TU þ LNG treatments. We then directly compared the 109 transcripts induced by TU alone with the 207 transcripts induced by TU þ LNG, and we found 63 transcripts in the TU þ LNG group that were significantly (P , 0.05) altered that showed no change with TU alone. On the other hand, TU treatment resulted in eight transcripts with significant (P , 0.05) changes that were not observed in the TU þ LNG treatment group (Supplemental Data).
As expected, the expressions of a Leydig cell-specific gene, insulin-like 3 (INSL3), and a Sertoli cell-specific gene, inhibin alpha (INHA), were suppressed by both TU and TU þ LNG treatments, respectively (Fig. 4) . Both TU and TU þ LNG treatments induced significant suppression of CYP17A1 gene expression compared with control in human testes.
Effects of TU Treatment on Testicular Gene Expression
Functional annotated groups of genes that displayed significant transcriptional changes (P , 0.05) induced by TU alone are shown in Table 1 . The major biologic processes affected by TU treatment were receptor binding, signal transduction, cytokine activity, growth factor activity, and apoptosis. Apoptotic signaling pathway genes were activated 2 wk after starting hormonal treatment. For example, TU treatment induced a 2.06-fold increase in IGFBP3 and a 2.02-fold increase in BCL2-like 14 (BCL2L14). Conversely, 
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TU treatment alone resulted in a 2.11-fold decrease in X-liked inhibitor of apoptosis protein (XIAP) and suppressed intratesticular growth factor gene expression. Growth differentiation factor 10 (GDF10) and nephroblastoma overexpressed gene (NOV) were decreased in 2.18-fold and 2.94-fold, respectively. The TU treatment also decreased cell cycle regulation gene CHK2 checkpoint homology (CHEK2) and transcription factor Dp-2 (TFDP2) expression by 2.72-fold and 2.82-fold, respectively.
Effects of TU treatment on testicular gene expression can be further shown in Figure 2 : a group of genes at the top of the panel showing TU alone was significantly increased compared with control and moderately upregulated compared with TU þ LNG treatment. For example, TU treatment alone significantly upregulated the gene expression of ciliary neurotrophic factor (CNTF), chemokine (C-C motif) ligand 18 (CCL18), thrombopoietin (THPO), small heat shock protein B9 (HSPB9), and ribonuclease H1 (RNASEH1), which were not changed by TU þ LNG treatment. Whether this implies different mechanisms of action of TU and LNG on some genes, differences in the levels of the hormones in the subjects, or differential sensitivity of the subjects in the two groups is not clear.
Effects of TU þ LNG Treatment on Testicular Gene Expression
Functional annotated groups of genes that displayed significant transcriptional changes (P , 0.05) induced by TU þ LNG treatment are shown in Table 2 . Addition of LNG to TU treatment not only resulted in 63 expressed genes that were significantly different from TU treatment alone, but also affected the biologic processes of alternative splicing, RNA binding, GTPase binding, cell junction, and immune response ( Table 2 ). In addition to the pathways activated by TU treatment alone, TUþLNG had a greater impact on insulin/ IGF/relaxin signaling, posttranscriptional regulation, and apoptosis ( Table 3 ). The TU þ LNG treatment suppressed INSL3 gene expression and increased insulin-like 6 (INSL6) and relaxin 1 (RLN1) expression. Interestingly, TU þ LNG treatment induced a significant (P , 0.05) suppression of a major proportion of the transcripts encoding RNA-binding proteins compared with TU treatment alone. Treatment with TU þ LNG increased apoptosis-related molecules ring finger protein 216 (RNF216), and it decreased apoptosis inhibitor 5 (API5), death-associated protein 3 (DAP3), pleiomorphic adenoma gene-like 1 (PLAGL1), and reticulon 4 (RTN4). In addition, PathwayArchitect analysis (Stratagene, La Jolla, CA) with genes differentially expressed in the TU þ LNG treatment group suggested a possible functional linkage among IGFBP3, CHK2 checkpoint homolog (CHEK2), and cell division cycle 25C (CDC25C), which might be involved in the suppression of spermatogenesis in men (Table 3) .
Immunolocalization of IGFBP3 in Human Testes
To further validate the correlation of transcript changes to their corresponding protein expression in human testes, we selected IGFBP3 as an example molecule to examine its localization by immunohistochemistry. We found that IGFBP3 was expressed and localized abundantly in Leydig cells and moderately in Sertoli cells and spermatocytes and round spermatids. After TU or TU þ LNG treatment, there was apparently increased expression of IGFBP3 in Sertoli cells compared with controls (Fig. 5) .
DISCUSSION
Using RNA isolated from human testicular open biopsies, we were able to detect the effects of TU and TU þ LNG on 38 500 gene expressions simultaneously in the testis. In fact, gene expression data generated from testicular biopsy represents a snapshot of gene transcription profile in a given time. We did not measure gonadotropin levels 2 wk after TU and TU þ LNG treatment, but at 3 wk both LH and FSH were suppressed in both groups of men [4] . A recent microarraybased study on RNA from human testicular needle biopsies following 4 wk of gonadotropin suppression induced by gonadotropin-releasing hormone antagonist plus testosterone showed a small subset of gene changes involved in steroidogenesis, early meiosis, and Sertoli-germ cell junctions [14] . In the present study, we demonstrated that compared with control, TU þ LNG induced more changes in gene expression (207 genes) than TU treatment (109 genes) at 2 wk. Comparing the gene expression between TU þ LNG treatment and TU alone, we found 63 transcripts in the TU þ LNG group were significantly (P , 0.05) altered that showed no change with TU treatment alone. In contrast, TU treatment only resulted in eight transcripts with significant (P , 0.05) changes that were not observed with TU þ LNG treatment. This was probably due to earlier, consistent, and enhanced suppression of gonadotropin with combined TU þ LNG treatment compared with TU alone [4, 15] , although the possibility of direct action of the progestin on the testis cannot be excluded [16] .
Our data showed the gene expressions of INSL3, a Leydig cell functional marker, and INHA, a Sertoli cell functional marker, were markedly suppressed after 2 wk of treatment with TU or TU þ LNG. Insulin-like 3, also known as Leydig insulin-like protein or relaxinlike factor, is expressed in Leydig cells in testes and is responsible for the descent of the testis to the scrotum [17] . INSL3 deficiency in mice causes bilateral cryptorchidism [18, 19] . The TU þ LNG-treated men who escape the complete spermatogenic suppression have higher serum INSL3 levels [20] . Thus, a decrease in INL3 gene expression provides further support that Leydig call function is suppressed by exogenous testosterone and progestin administration. Inhibin is a gonadal glycoprotein hormone secreted by the Sertoli cells that regulates FSH secretion, and it also functions in vivo as a tumor suppressor in the mouse gonads [21] . Decreased INHA expression after testicular hormonal deprivation suggests Sertoli cell function is suppressed by exogenous hormone treatment. Suppression of Leydig and Sertoli cell functional markers due to inhibition of gonadotropin secretion after exogenous TU and TU þ LNG treatment is anticipated and substantiates the validity of our gene microarray data.
We demonstrated that both TU and TU þ LNG treatment suppressed the gene expression of CYP17A1 encoding 17a-hydroxylase/17,20 lyase (a rate-limiting steroidogenic enzyme for testosterone production in Leydig cells). In addition to its well-known function in the androgen biosynthesis in Leydig cells, a recent study reported that 17a-hydroxylase/17,20 lyase encoded by CYP17A1 is present in germ cells and essential for sperm function. Haploinsufficiency of CYP17 is a cause of male infertility in mice [22, 23] . Thus, TU þ LNG-induced rapid suppression of spermatogenesis may be due to a marked We have demonstrated previously that one of the major mechanisms of suppression of spermatogenesis caused by deprivation of hormones in the testis is due to increased germ cell apoptosis [4] [5] [6] 24] . Our gene microarray experiment confirmed that both TU and TU þ LNG treatment activated the apoptotic signaling pathway in the testis. We found, for example, that both TU and TU þ LNG treatment increased proapoptotic BCL2-like 14 expression and decreased antiapoptotic X-linked inhibitor of apoptosis protein (XIAP) [25] . BCL2-like 14 (BCL2L14) is a novel proapoptotic member of the BCL2 family. BCL2L14 encodes two proteins through alternative mRNA splicing, BCL2L14L (long) and BCL2L14s (short). BCL2L14L mRNA is expressed widely in adult human tissues, whereas BCL2L14s mRNA is found only in testis and is more potent in inducing apoptosis than BCL2L14L [26] . XIAP inhibits apoptosis by inhibiting caspases [27] .
We also demonstrated that both TU and TU þ LNG treatments increased the expression of IGFBP3. IGFBP3, the major circulating carrier protein for IGF1, is active in the cellular environment as a potent antiproliferative agent. The increased IGFBP3 gene expression after TU or TU þ LNG treatment suggests that this protein may participate in the suppression of spermatogenesis by binding to IGF1 and IGF2 to reduce the bioavailability of these two paracrine growth factors for both spermatogenesis and steroidogenesis [28] [29] [30] [31] . IGFBP3 causes cell cycle blockage and induces apoptosis [32, 33] . IGFBP3 has been reported to be localized in rat Leydig cells and porcine Sertoli cells [34, 35] . We showed by immunohistochemistry that IGFBP3 was expressed and localized in Leydig cells, Sertoli cells, spermatocytes, and round spermatids in human testes. Thus, IGFBP3 may have an action in male germ cells that are independent of sequestration of IGFs and may induce apoptosis directly similar to its proapoptotic actions in the prostate and other tissues [36, 37] .
Functional clustering analysis showed that TU þ LNG treatment activated insulin/IGF/relaxin signaling pathway in human testes. The TU þ LNG treatment induced increases in expression of RLN1 and INSL6. Relaxin protein shares structure similarity with insulin and IGFs. The major physiologic function of relaxin is its actions on collagen remodeling. Mice with relaxin overexpression are fertile [38] . Relaxin knockout male mice show delayed tissue maturation and growth in the testes, epididymides, and prostate associated with increased collagen deposition [39] . INSL6, a member of the insulin gene family, is expressed in human testes, and its transcripts are localized in spermatocytes and round spermatids [40] . INSL6 is a secreted protein localized to the endoplasmic reticulum and Golgi in transfected cells [41] . However, the physiologic role of relaxin and insulin-like 6 in testes remains to be determined.
RNA-binding proteins play pivotal roles in the regulation of spermatogenesis. In comparison with TU treatment alone, addition of LNG to TU significantly suppressed a major portion of transcripts encoding RNA-binding proteins. Interestingly, a group of downregulated transcripts (HNRNPA3, HNRNPD, SNRPN, TRA2A, and SFRS15) encode RNAbinding proteins that act on pre-mRNA processing. We have demonstrated that spermatocytes and round spermatids are cells most susceptible to apoptosis in response to both testicular hormonal deprivation and elevated testicular temperature [42] .
A growing body of literature demonstrated that disruption of RNA-binding proteins that are involved RNA processing, transport, and metabolism in testes resulted in infertility that mainly affects meiotic and postmeiotic germ cell development [43] [44] [45] . Thus, our data generated from human testis samples provided evidence showing that the rapid suppression of spermatogenesis induced by TU þ LNG treatment may be the consequence of suppression of RNA-binding protein expression decreasing the gene posttranscription machinery in human testes.
Spermatogenesis includes precisely regulated mitosis and meiosis. Cell cycle regulation is another critical process affected by both TU and TU þ LNG treatments. We found the expression of cyclin-dependent kinase inhibitor 2D (CDKN2D), also known as p19 INK4d , was increased. The protein encoded by CDKN2D is a member of the INK4 family of cyclin-dependent kinase inhibitors that can block cell cycle G 1 progression. CDKN2D is mainly localized in spermatocytes, with some expression in the spermatids of human testes [46] . Evidence from CDKN2D-deficient mice indicates CDKN2D is involved in the transition from mitotic to meiotic division in germ cells [47, 48] . Increased expression of CDKN2D at 2 wk after treatment suggests that TU þ LNG treatment suppresses B spermatogonia entering into meiosis in human testes. In addition, TU þ LNG treatment altered CHK2 checkpoint homolog (CHEK2) and cell division cycle 25C (CDC25C) gene expression. CHK2 encodes checkpoint kinase 2 (CHK2), which can be rapidly activated in response to replication blocks and DNA damage. The activated CHK2 inhibits CDC25C phosphatase to prevent cell entry into the cell cycle [49] . CHK2 is localized abundantly in adult spermatogonia and weakly in some spermatocytes of human testes [50] . Phosphatase CDC25C is localized to the nucleus of late spermatocytes and round spermatids of rodent testes [51, 52] . The downregulation of CHEK2 and upregulation of CDC25C indicate that TU þ LNG treatment may weaken the cell cycle checkpoint and allow accumulation of DNA damage to trigger apoptosis.
Both TU and TU þ LNG treatment induced alteration of gene expression related to cell junctional molecules and immune response in testes. Androgen may regulate the permeability of the blood-testis barrier. Sertoli cell-specific ablation of androgen receptor results in increased permeability of the blood-testis barrier to biotin in mice [53] . Our gene microarray data showed that both TU and TU þ LNG treatment increased expression of desmoglein 1 (DSG1), one of the molecules forming desmosome, and gap junction protein alpha 10 (GJA10). The TU þ LNG treatment decreased the expression of plakophilin 4 (PKP4) and par-6 partitioningdefective 6-homolog beta (PARD6B), which may be involved in regulating junctional plaque organization and formation of epithelial tight junctions. In addition, clinical studies have shown a positive correlation between progesterone concentration and increased inflammatory cytokines in healthy men [54] . Both TU and TU þ LNG treatment upregulated transcripts encoding proteins related to antigen presentation, which include interferon gamma-inducible protein 30 (IFI30), Cd86 antigen (CD86), leukocyte immunoglobulin-like receptor subfamily B (LILRB1), major histocompatibility complex class II (HLA-DQB1), chemokine ligand 18 (CCL18), and chemokine ligand 10 (CXCL10). CXCL10, also known as interferon-c-inducible protein 10 (IP-10), is a potent chemokine expressed predominantly by macrophages and Leydig cells in the testis [55, 56] . Overexpression of CXCL10 by transfection in mouse Leydig MA-10 cells inhibits STAR D1 expression, decreases progesterone synthesis, and inhibits cell proliferation [57] . Thus, we speculate that the hormonal deprivation in human testes may result in a weakened blood-490 testis barrier and cause germ cell-specific antigen release from the luminal compartment of the seminiferous tubule into interstitial space to trigger the autoimmune response in the testis. In turn, immune response cytokines generated from macrophages and Leydig cells may diffuse into the seminiferous tubules to trigger germ cell apoptosis.
Taken together, we demonstrated that testosterone plus LNG induced suppression of spermatogenesis, which is most likely mediated through transcriptional and posttranscriptional regulation. Administration of TU or TU þ LNG not only suppresses gonadotropin levels but also inhibits the bioavailability of growth factors and RNA-binding proteins. The demonstration of significant upregulation of proapoptotic and downregulation of antiapoptotic transcripts further supports our belief that apoptosis is one of the major mechanisms resulting in suppression of spermatogenesis induced by intratesticular hormonal deprivation. We demonstrated for the first time that the rapid suppression of spermatogenesis by adding LNG to TU was due to activation of insulin/IGF/relaxin-related pathways and suppression of the availability of a major portion of RNA-binding proteins in human testes. We propose that increased IGFBP3 in the testes may play an important role in suppression of spermatogenesis by sequestering IGF's bioavailability and inducing germ cell apoptosis, leading to azoospermia and severe oligozoospermia. Importantly, our study has provided a novel and valuable database for the study of hormonal regulation of spermatogenesis in men and the discovery of testicular-specific molecules that may serve as potential targets for male contraceptive development.
